Gp. Vicent et al., 21-HYDROXY-6,19-OXIDOPROGESTERONE - A NOVEL SYNTHETIC STEROID WITH SPECIFIC ANTIGLUCOCORTICOID PROPERTIES IN THE RAT, Molecular pharmacology, 52(4), 1997, pp. 749-753
In the rat, the conformationally highly bent steroid 21-hydroxy-6,19-o
xidoprogesterone efficiently displaces [H-3]corticosterone from thymus
-glucocorticoid receptors and blocks type II receptors in kidney cytos
ols but competes with neither [H-3]aldosterone for kidney-mineralocort
icoid receptors nor [H-3]progesterone for uterus-progesterone receptor
s. It evokes Na+ retention only at very high doses (similar to 100 mu
g/100 g of rat weight) and is unable to induce tyrosine aminotransfera
se or to increase glycogen deposits in rat liver. When coincubated wit
h corticosterone or dexamethasone, 2.5 mu M 21OH-6OP inhibits 80% of t
yrosine aminotransferase induction. It may therefore be used experimen
tally as an antiglucocorticoid virtually lacking mineralocorticoid or
glucocorticoid properties as well as affinity for mineralocorticoid or
progesterone receptors.